NCT03981419View on ClinicalTrials.gov

A Study to Evaluate the Effect of GRF6021 on Postoperative Recovery Following Primary Hip or Knee Arthroplasty

PHASE2CompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

July 12, 2019

Primary Completion Date

January 23, 2021

Study Completion Date

March 4, 2021

Conditions
Postoperative Recovery
Interventions
BIOLOGICAL

GRF6021

for IV infusion

OTHER

Placebo

for IV infusion

Trial Locations (1)

94305

Stanford University Medical Center, Palo Alto

Sponsors

Lead Sponsor

Alkahest, Inc.
All Listed Sponsors
lead

Alkahest, Inc.

INDUSTRY